دورية أكاديمية
Modeling Poliovirus Transmission and Responses in New York State.
| العنوان: | Modeling Poliovirus Transmission and Responses in New York State. |
|---|---|
| المؤلفون: | Thompson KM; Kid Risk, Inc, Orlando, Florida, USA., Kalkowska DA; Kid Risk, Inc, Orlando, Florida, USA., Routh JA; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Brenner IR; Office of Public Health, New York State Department of Health, Albany, New York, USA., Rosenberg ES; Office of Public Health, New York State Department of Health, Albany, New York, USA.; Department of Epidemiology and Biostatistics, State University of New York at Albany, Albany, New York, USA., Zucker JR; New York City Department of Health and Mental Hygiene, New York, New York, USA.; Immunization Services Division, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Langdon-Embry M; New York City Department of Health and Mental Hygiene, New York, New York, USA., Sugerman DE; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Burns CC; Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Badizadegan K; Kid Risk, Inc, Orlando, Florida, USA. |
| المصدر: | The Journal of infectious diseases [J Infect Dis] 2024 Apr 12; Vol. 229 (4), pp. 1097-1106. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| أسماء مطبوعة: | Publication: Jan. 2011- : Oxford : Oxford University Press Original Publication: 1904-2010 : Chicago, IL : University of Chicago Press |
| مواضيع طبية MeSH: | Poliomyelitis*/epidemiology , Poliomyelitis*/prevention & control , Poliovirus*/genetics, Humans ; Disease Outbreaks/prevention & control ; New York/epidemiology ; Poliovirus Vaccine, Inactivated ; Poliovirus Vaccine, Oral ; Wastewater-Based Epidemiological Monitoring |
| مستخلص: | Background: In July 2022, New York State (NYS) reported a case of paralytic polio in an unvaccinated young adult, and subsequent wastewater surveillance confirmed sustained local transmission of type 2 vaccine-derived poliovirus (VDPV2) in NYS with genetic linkage to the paralyzed patient. Methods: We adapted an established poliovirus transmission and oral poliovirus vaccine evolution model to characterize dynamics of poliovirus transmission in NYS, including consideration of the immunization activities performed as part of the declared state of emergency. Results: Despite sustained transmission of imported VDPV2 in NYS involving potentially thousands of individuals (depending on seasonality, population structure, and mixing assumptions) in 2022, the expected number of additional paralytic cases in years 2023 and beyond is small (less than 0.5). However, continued transmission and/or reintroduction of poliovirus into NYS and other populations remains a possible risk in communities that do not achieve and maintain high immunization coverage. Conclusions: In countries such as the United States that use only inactivated poliovirus vaccine, even with high average immunization coverage, imported polioviruses may circulate and pose a small but nonzero risk of causing paralysis in nonimmune individuals. Competing Interests: Potential conflicts of interest. All authors: no reported conflicts. All authors have submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Conflicts that the editors consider relevant to the content of the manuscript have been disclosed. (Published by Oxford University Press on behalf of Infectious Diseases Society of America 2023.) |
| References: | MMWR Morb Mortal Wkly Rep. 2022 Aug 19;71(33):1065-1068. (PMID: 35980868) J Infect Dis. 2014 Nov 1;210 Suppl 1:S424-33. (PMID: 25316864) J Infect Dis. 2015 Jun 1;211(11):1800-12. (PMID: 25505296) JAMA Netw Open. 2023 Jan 3;6(1):e2249710. (PMID: 36602797) Vaccine. 2015 Mar 24;33(13):1568-77. (PMID: 25701673) PLOS Glob Public Health. 2023 Jan 26;3(1):e0001062. (PMID: 36962986) Risk Anal. 2016 Jul;36(7):1418-26. (PMID: 26033542) Risk Anal. 2021 Feb;41(2):248-265. (PMID: 31960533) Risk Anal. 2021 Feb;41(2):376-386. (PMID: 33084153) J Infect Dis. 2009 Feb 1;199(3):391-7. (PMID: 19090774) BMC Infect Dis. 2015 Sep 17;15:376. (PMID: 26382234) MMWR Morb Mortal Wkly Rep. 2022 Nov 04;71(44):1418-1424. (PMID: 36327157) Lancet. 2022 Oct 1;400(10358):1079. (PMID: 36183713) Risk Anal. 2013 Apr;33(4):647-63. (PMID: 22985171) Public Health Rep. 2012 Jan-Feb;127(1):23-37. (PMID: 22298920) Euro Surveill. 2022 Sep;27(37):. (PMID: 36111556) Euro Surveill. 2013 Sep 19;18(38):. (PMID: 24084337) MMWR Morb Mortal Wkly Rep. 2014 Aug 22;63(33):721-4. (PMID: 25144542) Risk Anal. 2013 Apr;33(4):680-702. (PMID: 23470192) Risk Anal. 2013 Apr;33(4):703-49. (PMID: 23521018) Risk Anal. 2006 Dec;26(6):1423-40. (PMID: 17184390) J Infect Dis. 2022 Oct 17;226(8):1309-1318. (PMID: 35415741) N Engl J Med. 2011 Jun 16;364(24):2316-23. (PMID: 21675890) Lancet Glob Health. 2022 Dec;10(12):e1807-e1814. (PMID: 36400086) Lancet. 2022 Oct 29;400(10362):1531-1538. (PMID: 36243024) Epidemiol Infect. 2019 Oct 24;147:e295. (PMID: 31647050) MMWR Morb Mortal Wkly Rep. 2023 Jan 13;72(2):26-32. (PMID: 36634005) |
| معلومات مُعتمدة: | CC999999 United States ImCDC Intramural CDC HHS; NU2RGH001915 United States AA NIAAA NIH HHS; NU2RGH001915-02-00 United States CC CDC HHS |
| فهرسة مساهمة: | Keywords: New York; immunization; modeling; outbreak; polio |
| المشرفين على المادة: | 0 (Poliovirus Vaccine, Inactivated) 0 (Poliovirus Vaccine, Oral) |
| تواريخ الأحداث: | Date Created: 20230819 Date Completed: 20240415 Latest Revision: 20240923 |
| رمز التحديث: | 20240923 |
| مُعرف محوري في PubMed: | PMC11284859 |
| DOI: | 10.1093/infdis/jiad355 |
| PMID: | 37596838 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiad355 |